Market Tracker

08/27 6:01pm ET

Vanguard Health Care Index Fund ETF Shares (VHT)

During the Trading Day
135.11 +2.57 / +1.94%
As of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
135.20 +0.09 / +0.07%
 
Volume: 500.00

Investment Objective

The investment seeks to track the performance of a benchmark index. The fund employs an indexing investment approach designed to track the performance of the MSCI US Investable Market Index (IMI)/Health Care 25/50, an index made up of stocks of large, mid-size, and small U.S. companies within the health care sector, as classified under the Global Industry Classification Standard (GICS). It attempts to replicate the target index by investing all, or substantially all, of its assets in the stocks that make up the index, holding each stock in approximately the same proportion as its weighting in the index. The fund is non-diversified.

No recent news for Vanguard Health Care Index Fund ETF Shares.

Performance

1 month-6.02% 3 years+25.16%
3 months-4.23% 5 years+23.30%
1 year+14.51% Since inception+10.09%
Data through 08/27/2015

Quote Details

Previous close$132.54
Open day’s range132.45 – 135.46
Net asset value (NAV)132.49 (08/26/2015)
Daily volume817,074
Average volume (3 months)392,811
Data as of 3:59pm ET, 08/27/2015

Peer Comparisonvs. Health ETFs

 VHTCategory
Performance 5-yr return+23.30%+26.72%
Expense Gross exp ratio0.12%0.46%
Risk 5 year sharpe ratio2.071.76
Net assets$7.3B$2.2B
Average market cap$50.1B$38.7B
Average P/E25.226.0
Dividend / Share--0.21%

Competitors

XLV Health Care Select Sector SPDR® Fund
RYH Guggenheim S&P 500® Equal Weight Health...
IXJ iShares Global Healthcare ETF

Holdings

Top 5 Sectors
Portfolio weighting
Healthcare 97.05%
Hardware 1.62%
Business service 0.22%
Financial service 0.05%
Consumer service 0.02%
Top 10 Holdings
Portfolio weighting
JNJ Johnson & Johnson7.93%
PFE Pfizer6.29%
GILD Gilead Sciences5.00%
MRK Merck4.76%
AMGN Amgen3.81%
AGN Allergan3.55%
ABBV AbbVie3.43%
UNH UnitedHealth3.29%
MDT Medtronic PLC3.16%
BMY Bristol-Myers Squibb3.10%